UBE2CP3 and hepatocellular carcinoma: For example, lncRNA CARLo‐5 facilitated HCC progression by inhibiting miR‐200b (Dou et al., 2017), and lncRNA UBE2CP3 promoted epithelial‐to‐mesenchymal transition (EMT) to induce metastasis in HCC (Cao et al., 2017).